← All companies
Moderna, Inc.
MRNA - CIK 0001682852
Market cap$18.86 B
Rank#643
SEC filings1,447
The table below shows Moderna, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.91B | $1.13B | $1.28B | $1.62B | $1.64B | $2.48B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $71.00M | $1.05B | $36.00M | $78.00M | $1.56B | $163.00M |
| Inventory | $146.00M | $332.00M | $240.00M | $128.00M | $412.00M | $399.00M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.